US Fertility AI Market Strategy Report - IVF Clinics

Answer Capsule

US Fertility holds the weakest recommendation position among all ten tracked IVF clinic brands in the September 2026 LLM Authority Index benchmark, recording zero valid recommendations despite appearing in 8 qualified observations. The brand's raw mention presence rate of 2.42% shows that AI systems occasionally surface US Fertility by name, but never convert that presence into an actual clinic recommendation. With no positive mentions, no top-three placements, and no rank-one recommendations across any tracked platform, US Fertility demonstrates visibility without recommendation conversion. The clearest opportunity lies in rebuilding the public evidence layer so AI systems have reason to recommend the brand rather than merely reference it.

Who This Report Is For

This report is for marketing, growth, and executive leadership at US Fertility responsible for understanding how AI search and chat platforms present the brand during IVF clinic discovery and evaluation.

Report Card

Executive Summary

US Fertility holds the weakest recommendation position in the September 2026 IVF Clinics benchmark. The brand appeared in 8 of 331 qualified observations, a raw mention presence rate of 2.42%, yet received zero valid recommendations, zero top-three placements, and zero rank-one recommendations. Every one of those 8 mentions was classified as neutral, meaning AI systems referenced US Fertility without endorsing it or recommending it to prospective patients.

The benchmark shows a category where CCRM Fertility leads valid recommendation coverage at 31.7%, followed by Shady Grove Fertility at 22.7% and RMA Network at 21.4%. US Fertility sits at the bottom of the ten-brand competitive set with 0.0% valid recommendation coverage, below Extend Fertility at 0.9% and Boston IVF at 3.6%. The brand's absence from recommendation lists is consistent across all six tracked AI surfaces.

US Fertility's strongest platform signal is essentially neutral presence without recommendation intent. The brand appeared in ChatGPT, Copilot, Gemini, Perplexity, and AI Mode responses, but never as a recommended option. The clearest platform gap is AI Overviews, where US Fertility recorded zero mentions across 98 observations, meaning Google's AI Overviews did not surface the brand even once.

The core issue is not visibility alone. US Fertility achieves occasional presence but fails to convert that presence into recommendation-stage eligibility. The public evidence layer appears to support reference-level mentions without the attributes, comparisons, or trust signals that lead AI systems to recommend one clinic over another.

What US Fertility Is Winning

US Fertility has no positive recommendation wins in the September 2026 dataset. The brand recorded zero positive mentions, zero valid recommendations, zero top-three placements, and zero rank-one recommendations across all tracked platforms.

The only measurable positive is the absence of negative framing. US Fertility recorded zero negative mentions, meaning AI systems did not caution against the brand. This is a narrow and limited finding, not a competitive strength. Neutral presence without negative sentiment provides a foundation, but it does not translate into recommendation power.

US Fertility did achieve presence across five of six tracked platforms, appearing in ChatGPT, Copilot, Gemini, Perplexity, and AI Mode responses. This breadth of surface presence, while minimal in volume, shows that the brand is not entirely absent from the AI information environment.

Where US Fertility Has the Clearest AI Visibility Gaps

US Fertility's central problem is presence without recommendation conversion. The brand appeared in 8 qualified observations but was never recommended. Every competitor that appeared in AI responses at least occasionally converted some presence into valid recommendations, with the exception of US Fertility.

The gap is starkest when compared to the category leader. CCRM Fertility converted 105 of 182 mentions into valid recommendations, a conversion dynamic that supports its 31.7% coverage rate. US Fertility converted 0 of 8 mentions into valid recommendations. The brand is present in the conversation but never selected.

AI Overviews represents the clearest platform gap. Across 98 AI Overviews observations, US Fertility recorded zero mentions. Competitors like CCRM Fertility appeared in 63 of those observations, and Shady Grove Fertility appeared in 51. US Fertility is entirely absent from the surface where several competitors hold their strongest recommendation positions.

The brand's neutral-only framing compounds the problem. All 8 US Fertility mentions were neutral, producing a net sentiment score of 0.00. Competitors with meaningful recommendation presence, such as Columbia University Fertility Center at 0.93 and RMA Network at 0.66, show that positive framing correlates with recommendation behavior. US Fertility has no positive framing to build on.

Biggest Opportunity

US Fertility's clearest opportunity is to convert its existing neutral presence into positive recommendation coverage by strengthening the public evidence layer that AI systems use to form clinic recommendations. The brand already appears in AI responses across multiple platforms, which means retrieval is not the primary barrier. The barrier is that nothing in the surfaced evidence gives AI systems a reason to recommend US Fertility over competitors.

The path forward involves building the citation architecture and source footprint that supports recommendation-stage visibility. This means ensuring that third-party sources, clinical outcome references, fertility treatment comparisons, and patient-relevant content position US Fertility as a recommended option rather than a passing mention. The brand needs the kind of public evidence that supports positive framing and recommendation eligibility.

Competitive Landscape

Questions This Section Answers

• Where does US Fertility rank among the ten tracked IVF clinic brands in the September 2026 benchmark?
• Which competitors hold the strongest top-three and rank-one recommendation positions?
• How does US Fertility's recommendation conversion compare with brands like CCRM Fertility and Extend Fertility?

CCRM Fertility, Shady Grove Fertility, and RMA Network hold the strongest recommendation-stage positions in the IVF Clinics category, with CCRM Fertility leading valid recommendation coverage at 31.7%. US Fertility sits at the bottom of the competitive set with zero valid recommendations.

Average recommended rank covers rank-eligible recommendations only.

The table shows US Fertility as the only tracked brand with no top-three placements, no rank-one recommendations, and no rank-eligible recommendations at all. Every other brand in the competitive set, including Extend Fertility at 0.9% coverage, achieved at least one valid recommendation. US Fertility's neutral-only presence and zero recommendation conversion place it in a category of its own at the bottom of the market.

Prompt Evidence

ChatGPT / Best IVF Clinics Discovery & Evaluation Prompt: "Which fertility clinic should I choose?" Result: US Fertility appeared in the response but was not recommended, while competitors received valid recommendation credit.

Copilot / Best IVF Clinics Discovery & Evaluation Prompt: "What are the best IVF clinics?" Result: US Fertility was mentioned neutrally without being shortlisted, consistent with its presence-without-recommendation pattern.

Gemini / Best IVF Clinics Discovery & Evaluation Prompt: "Recommend a fertility clinic near me" Result: US Fertility appeared once in 53 observations but received no recommendation credit, while CCRM Fertility led the surface with 13 valid recommendations.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map which prompts and surfaces surface US Fertility by name and identify why those mentions never convert into recommendations.

Phase 2: Recommendation Readiness Plan Identify the specific attributes, comparisons, and trust signals that AI systems associate with recommended clinics and assess where US Fertility falls short.

Phase 3: Owned Answer Layer Buildout Develop owned content that answers high-intent fertility clinic questions with the specificity and framing that supports recommendation eligibility.

Phase 4: Citation / Authority Layer Development Build the third-party citation architecture and public evidence layer that gives AI systems reason to recommend US Fertility rather than reference it neutrally.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track monthly changes in presence, recommendation coverage, placement, and sentiment to measure whether the evidence layer improvements shift recommendation behavior.

Why This Matters

AI-generated recommendations are becoming the first filter in fertility clinic selection. When prospective patients ask AI systems which clinic to choose, the brands that receive valid recommendations and top-three placements shape the buyer shortlist before a patient ever visits a website. US Fertility's zero recommendation coverage means the brand is effectively absent from the consideration set that AI systems construct.

Presence alone is not enough. US Fertility appears in AI responses but never as a recommended option, and that distinction determines whether the brand enters the buyer shortlist. The next move is targeted correction of the prompt, page, and citation layers so that AI systems have the evidence needed to recommend US Fertility, not just mention it.

Core Metrics

Sentiment Score

Questions This Section Answers

• How is US Fertility's net sentiment score of 0.00 calculated?
• Why does the sentiment score matter when interpreting US Fertility's raw mention count?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For US Fertility, the calculation is (0 × 1 + 8 × 0 + 0 × -1) / 8, producing a net sentiment score of 0.00. This score reflects the balance of positive versus negative framing across the brand's mentions.

The sentiment score matters because unclassified mention counts are misleading. US Fertility's 8 mentions could appear meaningful without context, but all 8 are neutral references with no recommendation intent. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, and US Fertility's all-neutral profile shows why raw presence numbers can overstate a brand's actual position.

Sentiment by Platform

Questions This Section Answers

• What is the sentiment breakdown for US Fertility across each tracked AI platform?
• Where is US Fertility's clearest platform presence gap relative to its neutral-only mentions?

Methodology

1. This report is a benchmark-based analysis of US Fertility's AI recommendation visibility in the IVF Clinics vertical, drawn from the September 2026 LLM Authority Index AI Market Discovery Index. It is not a client implementation case study.
2. The reporting window is September 2026, with qualified observations collected and analyzed as of September 1, 2026.
3. Six AI surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Mode, and Google AI Overviews.
4. The benchmark began with 558 source prompt-surface observations, of which 399 were unique questions and 481 were relevant to the IVF Clinics vertical.
5. After qualification, 331 observations formed the public denominator for all brand-level metrics.
6. The competitor universe included 10 tracked brands: CCRM Fertility, Shady Grove Fertility, RMA Network, Columbia University Fertility Center, Pacific Fertility Center, Kindbody, Spring Fertility, Boston IVF, Extend Fertility, and US Fertility.
7. All qualified observations fell into the Brand Recommendation buyer-intent cluster. No qualified observations existed for Pricing & Value or Multi-Brand Comparison clusters.
8. Stage 0 extraction captured prompt-level observations including query, surface, answer, brand outcome, recommendation placement, sentiment, and citations where exposed.
9. A mention is defined as any appearance of a tracked brand in an AI response, regardless of context or framing.
10. A valid recommendation is defined as a clear recommendation of the brand within a qualified observation, distinct from a neutral reference or passing mention.
11. US Fertility's small mention count carries wider relative uncertainty; movements and patterns should be read as directional rather than definitive.
12. Month-over-month movement identifies changes worth investigating but does not by itself establish cause. Observed patterns may reflect shifts in AI model behavior, prompt composition, or broader information dynamics.

See How AI Is Recommending Your Brand

The public benchmark shows where US Fertility stands relative to competitors, but category-level percentages do not explain why the brand appears without being recommended. A company-level AI visibility audit maps the specific prompts, surfaces, competitor displacements, and evidence sources that shape US Fertility's recommendation outcomes, turning benchmark findings into a prioritized visibility strategy.